The Biomedical/Biotechnology Research Institute, North Carolina Central University, North Carolina Research Campus, Kannapolis, North Carolina, United States of America.
PLoS One. 2012;7(6):e39327. doi: 10.1371/journal.pone.0039327. Epub 2012 Jun 25.
Anemia is a hematologic disorder with decreased number of erythrocytes. Erythropoiesis, the process by which red blood cells differentiate, are conserved in humans, mice and zebrafish. The only known agents available to treat pathological anemia are erythropoietin and its biologic derivatives. However, erythropoietin therapy elicits unwanted side-effects, high cost and intravenous or subcutaneous injection, warranting the development of a more cost effective and non-peptide alternative. Ginger (Zingiber officinale) has been widely used in traditional medicine; however, to date there is no scientific research documenting the potential of ginger to stimulate hematopoiesis.
METHODOLOGY/PRINCIPAL FINDINGS: Here, we utilized gata1:dsRed transgenic zebrafish embryos to investigate the effect of ginger extract on hematopoiesis in vivo and we identified its bioactive component, 10-gingerol. We confirmed that ginger and 10-gingerol promote the expression of gata1 in erythroid cells and increase the expression of hematopoietic progenitor markers cmyb and scl. We also demonstrated that ginger and 10-gingerol can promote the hematopoietic recovery from acute hemolytic anemia in zebrafish, by quantifying the number of circulating erythroid cells in the dorsal aorta using video microscopy. We found that ginger and 10-gingerol treatment during gastrulation results in an increase of bmp2b and bmp7a expression, and their downstream effectors, gata2 and eve1. At later stages ginger and 10-gingerol can induce bmp2b/7a, cmyb, scl and lmo2 expression in the caudal hematopoietic tissue area. We further confirmed that Bmp/Smad pathway mediates this hematopoiesis promoting effect of ginger by using the Bmp-activated Bmp type I receptor kinase inhibitors dorsomorphin, LND193189 and DMH1.
CONCLUSIONS/SIGNIFICANCE: Our study provides a strong foundation to further evaluate the molecular mechanism of ginger and its bioactive components during hematopoiesis and to investigate their effects in adults. Our results will provide the basis for future research into the effect of ginger during mammalian hematopoiesis to develop novel erythropoiesis promoting agents.
贫血是一种血液学疾病,表现为红细胞数量减少。红细胞生成,即红细胞分化的过程,在人类、小鼠和斑马鱼中是保守的。目前可用的治疗病理性贫血的唯一药物是促红细胞生成素及其生物衍生药物。然而,促红细胞生成素治疗会引起不必要的副作用、高成本以及需要静脉或皮下注射,这就需要开发更具成本效益的非肽类替代物。生姜(Zingiber officinale)在传统医学中被广泛应用;然而,迄今为止,没有科学研究记录生姜刺激造血的潜力。
方法/主要发现:在这里,我们利用 gata1:dsRed 转基因斑马鱼胚胎研究了生姜提取物对体内造血的影响,并鉴定出其生物活性成分 10-姜酚。我们证实生姜和 10-姜酚可促进红细胞中 gata1 的表达,并增加造血祖细胞标记物 cmyb 和 scl 的表达。我们还表明,生姜和 10-姜酚可通过视频显微镜定量分析背主动脉中循环红细胞的数量,促进斑马鱼急性溶血性贫血的造血恢复。我们发现,在原肠胚形成期用生姜和 10-姜酚处理可增加 bmp2b 和 bmp7a 的表达及其下游效应物 gata2 和 eve1。在后期,生姜和 10-姜酚可诱导尾部造血组织区域的 bmp2b/7a、cmyb、scl 和 lmo2 表达。我们进一步证实,Bmp/Smad 途径通过使用 Bmp 激活的 Bmp 型 I 受体激酶抑制剂 dorsomorphin、LND193189 和 DMH1 来介导生姜的这种促造血作用。
结论/意义:我们的研究为进一步评估生姜及其生物活性成分在造血过程中的分子机制以及研究它们在成体中的作用提供了坚实的基础。我们的研究结果将为未来研究生姜在哺乳动物造血过程中的作用,开发新型促红细胞生成药物提供依据。